Hevolution Foundation Scientific Conferences Fund

Sponsor: The Hevolution Foundation

Award: Up to $10,000 per meeting

Due Date: January 31, 2024

Glenn Foundation Discovery Award

Sponsor: Glenn Foundation for Medical Research (GFMR) in collaboration with the American Federation for Aging Research

Award: Two awards of $525,000

Due Date: Deadline for Letters of Intent: February 15, 2024

Notice of Intent to Publish an FOA for Open Measurement Coordinating Network for Non-Pharmacological AD and ADRD Primary Prevention Trials (U24 Clinical Trial Not Allowed) (NOT-AG-23-061)

Sponsor: National Institute on Aging

Due Date: Estimated Publication Date of Notice of Funding Opportunity: February 01, 2024. First Estimated Application Due Date: June 07, 2024.

NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required) (PAR-23-311)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

NINDS Exploratory Clinical Trials for Small Business (R41/R42 Clinical Trial Required) (PAR-24-044)

Sponsor: National Institute of Neurological Disorders and Stroke

Due Date: Multiple due dates; see announcement.

Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional) (PAR-24-042)

Sponsor: National Institutes of Health

Award: Application budgets are limited to direct costs up to $50,000 per year and need to reflect the actual needs of the proposed project. The maximum period of support is 2 years.

Due Date: Multiple due dates; see announcement.

Initiative for Maximizing Student Development (IMSD) (T32) (PAR-24-031)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32) (PAR-24-032)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed) (PAR-24-052)

Sponsor: National Institute on Aging

Due Date: Multiple due dates; see announcement.

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) (PAR-24-043)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) (PAR-24-063)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Notice of Special Interest: Encourage Eligible NIH BRAIN Initiative Awardees to Apply for PA-23-189 Research Supplements to Promote Diversity in Health-Related Research (NOT-AA-23-020)

Sponsor: National Institutes of Health

Due Date: Applications are accepted on a continuing basis throughout the year up until November 30, 2026.

Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed) (RFA-EB-23-006)

Sponsor: National Institute of Biomedical Imaging and Bioengineering

Due Date: Multiple due dates; see announcement.

Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in Latin America: Setting the Stage for Better Health Outcomes Across the Hemisphere (R01) (PAR-23-303)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) (RFA-EY-23-001)

Sponsor: National Institutes of Health

Award: Application budgets may not exceed $400,000 total direct costs over a maximum three-year funding period. No more than $200,000 in direct costs may be requested in any single year.

Due Date: Multiple due dates; see announcement.